Mar 28,2018

Diabetes monitoring startup wins a $50,000 Seed Boost fund during Speed@BDD’s fifth Demo Day

Spike, a mobile assistant that helps diabetics better manage their diabetes, won the second edition of Speed@BDD’s Seed Boost. The startup took back home $50,000 equity investment (five percent) which will help it further grow and develop its product in the upcoming months prior to securing the next round of investment.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 05,2018

BeatO raises $1.3 million from Leo Capital, Blume Ventures

BeatO, a startup for diabetic patients, has raised an institutional funding of USD 1.3 million, led by Leo Capital and co-led by Blume Ventures. BeatO offers a smartphone-based glucometer. Started just over 2 years ago, BeatO currently serves 25,000 active customers in more than 1,500 cities.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Apr 09,2018

One Drop Raises $5.8M in Debt and Equity Round

One Drop received $5.8 million in an equity and debt round according to the SEC form registered.

FUNDING DEBT FINANCE
View Analyst & Ambassador Comments
Go to original news
Apr 25,2018

OurPath takes digital health to St. James’s Palace

After being selected as one of 42 startups in the United Kingdom to participate in the Pitch@Palace 9.0 Boot Camp, led by HRH The Duke of York – OurPath has been invited to pitch its digital health platform at St. James's Palace on April 25, 2018 in London.

FUNDING NON EQUITY ASSISTANCE
View Analyst & Ambassador Comments
Go to original news
Jun 13,2018

Personal Health Assistant Startup Brook Raises $4 Million

Seattle-based Brook Inc., a company developing a personal health assistant, raised $4 million in a Seed round, the company announced Tuesday. Buffalo-headquartered Independent Health, a Western New York State health plan, participated in the funding round.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Jun 29,2018

Senseonics closes $150m public offering

Senseonics said today that it closed an underwritten public offering of its common stock, reeling in $149.5 million in total proceeds. The Germantown, Md.-based company plans to use its newly-acquired funds to support the commercialization of its implantable continuous glucose monitoring system, Eversense.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Aug 08,2018

Tandem Diabetes Care Announces Closing of $115 Million Underwritten Public Offering of Common Stock

Tandem Diabetes Care today announced the closing of its previously announced underwritten public offering of 3,508,770 shares of common stock at a price to the public of $28.50 per share. In addition, the underwriters fully exercised an option to purchase 526,315 additional shares of common stock at the public offering price. All of the shares in the offering were offered by Tandem, with gross proceeds to Tandem of approximately $115 million.

FUNDING POST-IPO EQUITY
View Analyst & Ambassador Comments
Go to original news
Aug 10,2018

OurPath raises $3 Million in Mango Seed round

Second Nature have just raised $3 million in a funding round lead by Connect Ventures and managing partner, Sitar Teli, doubling down on its ambitions to tackle Type 2 diabetes.

FUNDING SEED ROUND
View Analyst & Ambassador Comments
Go to original news
Aug 22,2018

One Medical raises $350 million from Carlyle Group to help double up offices and offerings

One Medical has confirmed to TechCrunch it has closed on funding from the Carlyle Group for a new cash infusion worth $350 million. This announcement follows an earlier report this week One Medical was seeking to close a $200 million deal, on top of a possible $100 million in stock for the financing firm. However, we have since learned the deal is a tad higher, including $220 toward the primary equity investment and another $130 million in a secondary investment.

FUNDING PRIVATE EQUITY ROUND
View Analyst & Ambassador Comments
Go to original news
Oct 02,2018

$2 MILLION GRANT TO POWER BIONIC PANCREAS TRIALS

Beta Bionics announced October 9, 2018 that it has been awarded a grant up to $2 million by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which is part of the U.S. National Institutes of Health (NIH). Beta Bionics is a medical technology company using machine learning and artificial intelligence to develop and commercialize the world’s first autonomous bionic pancreas—the iLet system.

FUNDING GRANT
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES